NL-OMON48261
Recruiting
Not Applicable
EVALUATION OF BIOMARKERS OF ATOPIC DERMATITIS IN PEDIATRIC PATIENTS WHOSE DISEASE IS NOT ADEQUATELY CONTROLLED WITH TOPICAL PRESCRIPTION THERAPIES OR WHEN THOSE THERAPIES ARE NOT MEDICALLY ADVISABLE - PEDISTAD BIOMARKER STUDY
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sanofi-aventis
- Enrollment
- 12
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Participation in the OBS15333 pediatric AD registry
- •2\. Signed informed consent by the parent/legally acceptable
- •representative and assent by the participant appropriate to the
- •participant\*s age.
Exclusion Criteria
- •Not applicable
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
AMBITIOUSAtopic Dermatitis Biomarker Identification Trial in Omalizumab UsageSingle- arm trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitis - AMBITIOUSAMBITIOUS is a trial to identify potential markers underlying variability in response to Omalizumab (Xolair®) treatment in atopic dermatitisAtopische Dermatitis is a common inflammatory skin disease showing chronically relapsing eczema and high association with elevated serum IgE levels.MedDRA version: 14.0Level: LLTClassification code 10029264Term: Neurodermatitis aggravatedSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2010-018559-84-DEMedizinische Fakultät der technischen Universität Muenchen20
Active, not recruiting
Not Applicable
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)Dermatitis AtopicNCT03849716Sanofi266
Completed
Not Applicable
Biomarkers in Atopic Dermatitis and Psoriasis The NetherlandsAtopic dermatitisatopic eczema10014982NL-OMON48036Academisch Medisch Centrum110
Recruiting
Not Applicable
BIOMAD NL study<p>Atopic dermatitis, atopic eczema</p>NL-OMON21253Amsterdam UMC, Academic Medical Center110
Recruiting
Not Applicable
Investigating biomarkers for development of atopic dermatitis in early childhood using maternal-infant hair-related microRNAEczemaJPRN-UMIN000027834Departments of Pediatrics Juntendo University, Faculty of Medicine 3-1-3 Hongo, Bunkyo-ku TOKYO, 113-0033, JAPAN TEL +81-3-3813-3111 FAX +81-3-5800-1580500